Manipulating the Wnt/β-catenin signaling pathway to promote anti-tumor immune infiltration into the TME to sensitize ovarian cancer to ICB therapy

Document Details

Document Type
Pub Defense Publication
Publication Date
Jan 01, 2021
Source ID
10.1016/j.ygyno.2020.10.031

Entities

People

  • A. Katre
  • A.i. Londoño
  • C.b. Scalise
  • J.a. Wall
  • L.a. Norian
  • R.c. Arend
  • S. Meza-perez
  • T. Randall
  • W.j. Turbitt

Organizations

  • National Cancer Institute
  • United States Department of Defense